The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes and prognostic factors of radiotherapy with dexamethasone, etoposide, ifosfamide, and carboplatin (RT-DeVIC) for newly diagnosed, localized extranodal NK/T-cell lymphoma, nasal type (ENKL): a cooperative study in Japan.
 
Motoko Yamaguchi
Honoraria - Chugai Pharma; Eisai; Kyowa Hakko Kirin; Takeda; Zenyaku Kogyo
 
Ritsuro Suzuki
Honoraria - Bristol-Myers Squibb; Celgene; Chugai Pharma; Kyowa Hakko Kirin; Meiji Seika Kaisha; Mochida Pharmaceutical Co. Ltd.; MSD; Novartis; Otsuka; Sawai Pharmaceutical Co; Shionogi; Sumitomo Dainippon; Takeda
Consulting or Advisory Role - Gilead Sciences; Jazz Pharmaceuticals; Mundipharma
 
Masahiko Oguchi
No Relationships to Disclose
 
Naoko Asano
Honoraria - Chugai Pharma; Janssen; Kyowa Hakko Kirin
 
Jun Amaki
No Relationships to Disclose
 
Takeshi Maeda
No Relationships to Disclose
 
Nobuko Kubota
No Relationships to Disclose
 
Yukio Kobayashi
Consulting or Advisory Role - Celgene; Daiichi Sankyo; Pfizer
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Novartis (Inst); Pfizer (Inst)
 
Kyoko Ueda
Honoraria - Bristol-Myers Squibb; Eisai; GlaxoSmithKline K.K.; Novartis
 
Kana Miyazaki
Honoraria - Chugai Pharma; Takeda
 
Naoto Tomita
No Relationships to Disclose
 
Nodoka Sekiguchi
No Relationships to Disclose
 
Jun Takizawa
No Relationships to Disclose
 
Bungo Saito
No Relationships to Disclose
 
Tohru Murayama
Honoraria - Eisai; Kyowa Hakko Kirin
 
Toshihiko Ando
No Relationships to Disclose
 
Hideho Wada
No Relationships to Disclose
 
Rie Hyo
No Relationships to Disclose
 
Masatoshi Hasegawa
Honoraria - Chugai Pharma; Daiichi Sankyo; Elekta; Novartis; Otsuka
 
Naoyuki Katayama
Honoraria - Alexion Pharmaceuticals; Astellas Pharma; Bristol-Myers Squibb Japan; Celgene; Chugai Pharma; Daiichi Sankyo; Dainippon Sumitomo Pharma; Eisai; Kyowa Hakko Kirin; Nippon Shinyaku; Pfizer; Shionogi; Shire; Taisho Toyama Pharma; Takeda
Research Funding - Astellas Pharma (Inst); Chugai Pharma (Inst); Kyowa Hakko Kirin (Inst)